EXPEDITION-I: Efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis

Authors
Category Primary study
JournalJournal of Hepatology
Year 2017
This article has no abstract
Epistemonikos ID: 1619c2d3fa9b1b6aca12a30f00cc87f444ce17f6
First added on: Feb 09, 2025